Related references
Note: Only part of the references are listed.ATIM-31. ALLOGENEIC TUMOR LYSATE / AUTOLOGOUS DENDRITIC CELL VACCINES IN NEWLY DIAGNOSED GLIOBLASTOMA: CLINICAL TRIAL MC1272
Ian F. Parney et al.
NEURO-ONCOLOGY (2017)
IMST-16. TRANSLATABLE RNA NANOPARTICLES SUPPLANT DENDRITIC CELL VACCINES IN CELLULAR IMMUNOTHERAPY
Elias Sayour et al.
NEURO-ONCOLOGY (2017)
The development of dendritic cell vaccine-based immunotherapies for glioblastoma
David A. Reardon et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma
Nan Ji et al.
ONCOTARGET (2016)
Recent advances and future of immunotherapy for glioblastoma
Neha Kamran et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2016)
Novel vaccines for glioblastoma: clinical update and perspective
Evan K. Winograd et al.
IMMUNOTHERAPY (2016)
Advances in HSP27 and HSP90-targeting strategies for glioblastoma
Randy van Ommeren et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Pilot study of T cells redirected to EGFRvIII with a chimeric antigen receptor in patients with EGFRvIII plus glioblastoma.
Donald M. O'Rourke et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
Christine E. Brown et al.
CLINICAL CANCER RESEARCH (2015)
Armed hunter killers: discerning the role of adoptive T-cell transfer for glioblastoma
Heba Samaha et al.
IMMUNOTHERAPY (2015)
Heat shock protein vaccines against glioblastoma: from bench to bedside
Leonel Ampie et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
Duane A. Mitchell et al.
NATURE (2015)
Prospects of immune checkpoint modulators in the treatment of glioblastoma
Matthias Preusser et al.
NATURE REVIEWS NEUROLOGY (2015)
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
Anna Sophie Berghoff et al.
NEURO-ONCOLOGY (2015)
Novel Approaches to Pediatric Cancer: Immunotherapy
Payal A. Shah et al.
AIMS MEDICAL SCIENCE (2015)
EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss
John H. Sampson et al.
CLINICAL CANCER RESEARCH (2014)
Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors
Derek A. Wainwright et al.
CLINICAL CANCER RESEARCH (2014)
Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents
Giulio Tosti et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Vaccine therapies for patients with glioblastoma
Eli T. Sayegh et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
Orin Bloch et al.
NEURO-ONCOLOGY (2014)
Autoimmunity as a double agent in tumor killing and cancer promotion
Kevin H. Toomer et al.
FRONTIERS IN IMMUNOLOGY (2014)
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
Surasak Phuphanich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
Einar Osland Vik-Mo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Active immunotherapy using dendritic cells in the treatment of glioblastoma multiforme
Amade Bregy et al.
CANCER TREATMENT REVIEWS (2013)
Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein
Courtney A. Crane et al.
CLINICAL CANCER RESEARCH (2013)
Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas
Jing Zeng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates
Serena Pellegatta et al.
ONCOIMMUNOLOGY (2013)
Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol
Karsten Geletneky et al.
BMC CANCER (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
Robert M. Prins et al.
CLINICAL CANCER RESEARCH (2011)
Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
Camilo E. Fadul et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
John H. Sampson et al.
NEURO-ONCOLOGY (2011)
Survival analysis of 205 patients with glioblastoma multiforme: Clinical characteristics, treatment and prognosis in China
Xiangyu Ma et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma:: Biological and clinical results
FF Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
JM Markert et al.
GENE THERAPY (2000)
Share Paper
